
Alarsin Pharmaceuticals (India) Private Limited
Produces ayurvedic and unani pharmaceutical preparations.
Produces ayurvedic and unani pharmaceutical preparations.
Alarsin Pharmaceuticals (India) Private Limited (APIPL) was founded in India on 23 July 1955 and has a glorious history of 69 years and nine months.Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Alarsin Pharmaceuticals (India) Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Satish Almaula, Palash Patel, Ajay Patel, and One other member serve as directors at the Company.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
U24239MH1955PTC009609
009609
Private Limited Indian Non-Government Company
23 Jul 1955
30 Sep 2024
31 Mar 2024
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Satish Almaula ![]() | Director | 01-Dec-1974 | Current |
Palash Patel ![]() | Director | 15-Oct-1998 | Current |
Ajay Patel ![]() | Director | 15-Jun-2004 | Current |
Amar Patel ![]() | Director | 14-Feb-2005 | Current |
Alarsin Pharmaceuticals (India) Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 8.72% increase. The company also saw a slight improvement in profitability, with a 9.46% increase in profit. The company's net worth Soared by an impressive increase of 10.51%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2019, Alarsin Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Satish Almaula, Palash Patel and 1 more are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Alarsin Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Alarsin Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alarsin Pharmaceuticals (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Alarsin Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Alarsin Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Amar Kunjbihari Patel was appointed as a Director was appointed as a Director on 14 Feb 2005 & has been associated with this company since 20 years 2 months .
Ajay Kunjbihari Patel was appointed as a Director was appointed as a Director on 15 Jun 2004 & has been associated with this company since 20 years 10 months .
Palash Keshavlal Patel was appointed as a Director was appointed as a Director on 15 Oct 1998 & has been associated with this company since 26 years 6 months .
Satish Upendra Almaula was appointed as a Director was appointed as a Director on 01 Dec 1974 & has been associated with this company since 50 years 5 months .
Alarsin Pharmaceuticals (India) Private Limited was incorporated on 23 Jul 1955.
The authorized share capital of Alarsin Pharmaceuticals (India) Private Limited is ₹ 0.60 M and paid-up capital is ₹ 0.10 M.
Currently 4 directors are associated with Alarsin Pharmaceuticals (India) Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Alarsin Pharmaceuticals (India) Private Limited is Alarsin House A/32 Streetno 3 Opp Esic Hospital Midc Marol Andheri East India, Mumbai, Maharashtra, 400093.
The corporate identification number (CIN) of Alarsin Pharmaceuticals (India) Private Limited is U24239MH1955PTC009609 and the company number is 009609 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Alarsin Pharmaceuticals (India) Private Limited has risen by 8.72%.
The financial reports for the fiscal year 2022 indicates that The net worth of Alarsin Pharmaceuticals (India) Private Limited has experienced an upsurge of 10.51%.
The most recent Balance Sheet for Alarsin Pharmaceuticals (India) Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
SP